About American Pharmaceutical Review

American Pharmaceutical Review is the leading review journal for business and technology in the pharmaceutical industry throughout North America since 1998. Published seven times a year, APR provides unbiased editorial on topics such as drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing, and regulatory affairs. Each issue offers American Pharmaceutical Review's 40,000 readers of senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharm/biopharm manufacturing.

Editorial Mission: To provide industry professionals with the latest information on the tools, technologies, and processes to discover, develop, and manufacture quality pharmaceuticals safely and efficiently.

American Pharmaceutical Review is published by:
CompareNetworks, Inc.
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080

Click here for more information on a complimentary subscription.

Press Releases: [email protected]

Sales & Advertising: [email protected]

General Inquiry: [email protected]

    Meet the APR Team

    Mike Auerbach, Editor in Chief
    Email: [email protected] | Tel.: 973-896-0362

    Ashley Poste, Account Executive
    Email: [email protected] | Tel.: 650-243-5639

    Jeanely Hunt, MS, MBA, GM & Pharma Group Brand Leader
    Email: [email protected] | Tel.: 216-200-8022

    Jessica Clevenger, Senior Content Marketing Coordinator

    Douglas Franklin, Web Content Manager

    Jennifer Campbell, Senior Art Director

    Allison Kem Chelminiak, Layout Designer & Tradeshow Coordinator

    Brendan Raher, Director of Creative Services

    APR Editorial Advisory Board

    Shaukat Ali, PhDTechnical Support Manager, BASF Corporation

    Ghulam Shabir Arain, PhD, CSsci, CChem, FRSC, FCQI, Managing Director (DGS Pharma Consulting Ltd., UK)

    Katherine Bakeev, PhD, Director of Analytical Services and Support B&W Tek, Inc.

    Douglas J. Ball, MS, Diplomate, American Board of Toxicology Research Fellow, Drug Safety R&D, Pfizer Global Research & Development

    Suraj Baloda, PhD, Founder and President, SARMICON, LLC.

    Rory Budihandojo, Director, Quality Systems Audit, Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd.

    Harsh Chauhan, PhD, Assistant Professor, School of Pharmacy & Health Professions, Creighton University

    Robert V. Chimenti, Sr. Strategic Applications Engineer Innovative Photonic Solutions, Adjunct Professor, Rowan University

    Emil W. Ciurczak, PhD, Doramaxx Consulting

    Rick E. Cooley, Retired, Eli Lilly & Co., Inc.

    Weiguo Dai, PhD, Scientific Director, Janseen Fellow Drug Product Development, Johnson and Johnson

    Vivek Dave, PhD, Assistant Professor, Pharmaceutical Sciences, St. John Fisher College, Wegmans School of Pharmacy

    Michael Dong, PhD, Senior Scientist, Small Molecule Analytical Chemistry & Quality Control, Genentech

    Walter Dziki, PhD, Associate Research Fellow, Abbott Laboratories

    Stuart Farquharson, PhD, President & CEO, Real-Time Analyzers, Inc.

    John Finkbohner, PhD, Director, Regulatory Affairs, MedImmune

    Adam S. Goldstein, Sr. Manager, Clinical Purification Operations/Development, Genentech

    Davy Guilarme, PhD, Sr. Lecturer, School of Pharmaceutical Sciences, University of Geneva
    University of Lausanne

    Brian Lingfeng He, , Research Investigator, Bristol-Myers Squibb

    Ronald Iacocca, PhD, , Sr. Research Advisor, Product and Process Performance, Eli Lilly & Co.

    Maik W. Jornitz, VP of Business Development, G-Con Manufacturing, LLC

    Hemant N. Joshi, PhD, MBA, Principal, Tara Innovations LLC

    Ian Lewis, PhD, Marketing Manager, Kaiser Optical Systems, Inc.

    Ralph Lipp, PhD, President & CEO, Lipp Life Sciences LLC

    Jack Lysfjord, Principal Consultant, Lysfjord Consulting LLC

    Steven R. Maple, PhD, Head of Pharmaceutical Technology Development Dept., Lilly Research Laboratories, Eli Lilly & Co., Inc.

    Jerold M. Martin, Sr. VP, Scientific Affairs, Pall Life Sciences

    John P. Mayer, Sr. Research Scientist, Indiana University

    >Michael J. Miller, PhD, President, Microbiology Consultants, LLC

    Ronald W. Miller, PhD, MBA, President, Technology Consultant, Miller Pharmaceutical

    Ganapathy Mohan, PhD, Head of Global CMC Regulatory Affairs, Merck, Sharp and Dohme Corp.

    Shane R. Needham, PhD, Laboratory Director, Alturas Analytics, Inc.

    Daniel L. Norwood, MSPH, PhD, Distinguished Research Fellow, Boehringer Ingelheim Pharmaceuticals, Inc.

    Mehul Patel, Global Marketing Director, Endotoxin and Microbial Detection, Charles River

    David Radspinner, Director of Marketing & Applications Support for Bioprocess Production, Thermo Fisher Scientific

    Aniruddha M. Railkar, PhD, Director of CMC, Tarsa Therapeutics

    Gary E. Ritchie, President, Council for Near Infrared Spectroscopy

    Rodolfo J. Romanach, PhD, Professor of Chemistry, University of Puerto Rico, Mayaguez Campus

    Shouvik Roy, PhD, Principal Scientist, Organizational Unit Leader in Drug Product Engineering, Amgen

    Jim Rydzak, Investigator, Strategic Technology Division, GlaxoSmithKline

    Ken Seufert, Managing Director, North America, MEGGLE USA, Inc.

    Jaleel Shujath, Industry Strategist, Life Sciences, OpenText

    Charles A. Signorino, PhD, CEO, Emerson Resources

    Donald C. Singer, Global Lead Manager, Microbiology, R&D, GlaxoSmithKline

    Onkar N. Singh, PhD, MBA, Director, Pharmaceutical Development, CONRAD/Eastern Virginia Medical School

    Allen Templeton, PhD, Senior Director, Merck Research Laboratories

    Zhenyu Wang, PhD, Associate Principle Scientist & Group Leader Respiratory Product Development, Merck & Co.

    Larry Wigman, PhD, Sr. Scientific Manager, Genentech